<div id="readability-page-1"><p>In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on PACS Group Inc, with a price target of <span id="expert-recommendation-target">$47.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical. According to TipRanks, Hendrix has an average return of <span>4.6%</span> and a 51.76% success rate on recommended stocks. </p> <p>In addition to RBC Capital, PACS Group Inc also received a Buy from UBS’s A.J. Rice in a report issued on December 18. However, on December 7, TR | OpenAI – 4o reiterated a Hold rating on PACS Group Inc (NYSE: PACS).</p></div>

PACS

<p>RBC Capital's Ben Hendrix maintains a Buy rating on PACS Group Inc with a $47 price target. Hendrix, who covers the Healthcare sector, has a 4.6% average return and a 51.76% success rate on stock recommendations. UBS's A.J. Rice also issued a Buy rating, while TR reiterated a Hold rating on PACS Group Inc.</p>

RBC Capital Keeps Their Buy Rating on PACS Group Inc (PACS)